This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
ÉTODOLAC
INN: ÉTODOLAC
Data updated: 2026-04-11
Available in:
🇩🇪🇬🇧🇫🇷🇹🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
LABORATOIRES ETHYPHARM
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
(FR)
Source
BDPM_FR
M01AB08(WHO)
AU:S4(Prescription only)UK:POM(Prescription only)US:℞-only
(RS)-2-(1,8-Diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
41340-25-4Y
3308
7185
DB00749Y
3192Y
2M36281008
D00315Y
CHEBI:4909Y
ChEMBL622Y
DTXSID9020615
Interactive image
CCc2cccc3c1CCOC(CC)(CC(=O)O)c1[nH]c23
InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)YKey:NNYBQONXHNTVIJ-UHFFFAOYSA-NY
Etodolacis anonsteroidal anti-inflammatory drug(NSAID).
It was patented in 1971 and approved for medical use in 1985.It was approved in the U.S. in 1991.
In 2023, it was the 296th most commonly prescribed medication in the United States, with more than 400,000 prescriptions.